This inventor holds 8 USPTO granted patents and 11 published patent applications, plus 3 CIPO patents and 5 EPO patents. Top assignee: Pierre Fabre Medicament. Active years: 2013-2026.
Company Filing History:
Years Active: 2013-2026
Title: Innovations and Contributions of Thierry Wurch
Introduction
Thierry Wurch is a notable inventor based in Machilly, France, recognized for his significant contributions to the field of antibody engineering. With a total of seven patents to his name, Wurch has made strides in developing processes that enhance the functionality of monoclonal antibodies.
Latest Patents
One of Wurch's latest patents is focused on a process for the modulation of the antagonistic activity of a monoclonal antibody. This patent details a method for screening antibodies and improving their antagonistic activity against specific target molecules. The process involves reconfiguring the hinge region of the antibody by modifying its amino acid sequence. Another significant patent is for an anti-cMET antibody, which is designed to bind specifically to the human c-Met receptor. This antibody is capable of inhibiting the receptor's tyrosine kinase activity and has improved antagonistic properties, making it a potential medicament for cancer treatment.
Career Highlights
Throughout his career, Thierry Wurch has worked with prominent companies such as Pierre Fabre Medicament. His work in these organizations has contributed to advancements in medical treatments and therapeutic applications.
Collaborations
Wurch has collaborated with notable colleagues, including Liliane Goetsch and Cédric Bes, further enhancing the impact of his research and innovations.
Conclusion
Thierry Wurch's contributions to antibody engineering and his innovative patents highlight his role as a significant figure in the field. His work continues to influence advancements in medical science and therapeutic development.